Skip to main content
Fig. 2 | BMC Health Services Research

Fig. 2

From: The impact of the ‘Better Care Better Value’ prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental design

Fig. 2

Monthly cost of total ACEIs/ARBs, ACEIs and ARBs from April 2006 to March 2012. a time point when generic perindopril became available (October 2007); b: time point when BCBV policy was implemented (April 2009); c: time point when generic losartan launched (July 2010); ACEIs: Angiotensin converting enzyme inhibitors; ARBs: Angiotensin receptor blockers

Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us